Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct;46(10):4588-4600.
doi: 10.1007/s00261-021-03129-1. Epub 2021 Jun 2.

Dual contrast liver MRI: a pictorial illustration

Affiliations
Review

Dual contrast liver MRI: a pictorial illustration

Christopher L Welle et al. Abdom Radiol (NY). 2021 Oct.

Abstract

Liver magnetic resonance imaging (MRI) is a commonly performed imaging technique with multiple indications and applications. There are two general groups of contrast agents used when imaging the liver, extracellular contrast agents (ECA) and hepatobiliary agents (HBA), each of which has its own advantages and limitations. Liver MRI with ECA provides excellent information on abdominal vasculature and better quality multi-phasic studies for characterization of focal liver lesions. HBA improves lesion detection, provides information regarding liver function and can be helpful for evaluating biliary tree anatomy, excretion, anastomotic stenoses, or leaks. Most liver MRI studies are usually performed with one agent, however in some cases, a second study is performed with another agent to obtain additional information or confirm the findings in the first study. Administering both agents in a single exam can potentially eliminate the need for additional imaging in certain situations. In this pictorial review, the techniques and indications for dual contrast MRI will be detailed with multiple demonstrative examples.

Keywords: Extracellular contrast agent; Focal nodular hyperplasia; Hepatic adenoma; Hepatobiliary contrast agent; Liver metastases.

PubMed Disclaimer

Similar articles

References

    1. Davenport, M.S., et al., Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology, 2013. 266(2): p. 452-61. - DOI
    1. Motosugi, U., et al., An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging. Radiology, 2016. 279(1): p. 93-102. - DOI
    1. Pietryga, J.A., et al., Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. Radiology, 2014. 271(2): p. 426-34. - DOI
    1. Chen, L., et al., Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One, 2012. 7(11): p. e48681.
    1. Grazioli, L., et al., Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology, 2012. 262(2): p. 520-9. - DOI

LinkOut - more resources